October 18, 2021

The Queens County Citizen

Complete Canadian News World

The study found that the Modernna vaccine was better than Pfizer against severe COVID

The study found that the Modernna vaccine was better than Pfizer against severe COVID

Washington | The modern vaccine provides better long – term protection against the serious effects of COVID – 19, compared to Pfizer, according to a study released Friday by a leading U.S. health organization.

Also read: “Those who return to intensive care will not be vaccinated,” Dubey said

Researchers at the Centers for Disease Prevention and Control (CDC) analyzed a sample of approximately 3,700 adults admitted to the hospital for Kovid-19, associated with severe symptoms, between March 11 and August 15, 2021, the prevalence of the pre- and delta variant.

During this period, the Modernna vaccine was 93% effective against hospitalizations, the Pfizer vaccine 88% and the Johnson & Johnson vaccine 68% effective.

The loss of effectiveness of Pfizer’s vaccine over time is particularly noticeable: its efficacy rate drops from 91% to 77% after 120 days, from 14 days to 120 days after injection.

Compared to the same periods, the effectiveness rate of the modern vaccine increased from 93% to 92%.

Several recent studies are in the same direction, confirming the apparent dominance of the Modernna vaccine over Pfizer.

See also …

READ  Exelder: Cope accepted mediator proposal